Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Labrecque

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Biomolecular Screening|December 25, 2012
Novel methodology to identify TRPV1 antagonists independent of capsaicin activationStephen Zicha, Olivier Radresa, Patricia Laplante, et al.
Biochemical Pharmacology|July 4, 2006
Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4Simon P Fricker, Virginia Anastassov, Jennifer Cox, et al.
Journal of the American Chemical Society|September 28, 2011
Prospective CCR5 small molecule antagonist compound design using a combined mutagenesis/modeling approachMarkus Metz, Elyse Bourque, Jean Labrecque, et al.
Virology|March 11, 2011
HIV-1 entry inhibition by small-molecule CCR5 antagonists: a combined molecular modeling and mutant study using a high-throughput assayJean Labrecque, Markus Metz, Gloria Lau, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2012
Discovery of P2X3 selective antagonists for the treatment of chronic painLouis-David Cantin, Malken Bayrakdarian, Christophe Buon, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Biochemical Pharmacology|December 8, 2011
The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitorRenee M Mosi, Virginia Anastassova, Jennifer Cox, et al.
Biochemical Pharmacology|June 23, 2009
Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4Veronique Bodart, Virginia Anastassov, Marilyn C Darkes, et al.
Lab on a Chip|May 27, 2025
A combined digital microfluidic test for assessing infection and immunity status for viral disease in salivaN Sathishkumar, Jose Gilberto Camacho Valenzuela, Nguyen H Le, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Biomolecular Screening|December 25, 2012
Novel methodology to identify TRPV1 antagonists independent of capsaicin activationStephen Zicha, Olivier Radresa, Patricia Laplante, et al.
Biochemical Pharmacology|July 4, 2006
Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4Simon P Fricker, Virginia Anastassov, Jennifer Cox, et al.
Journal of the American Chemical Society|September 28, 2011
Prospective CCR5 small molecule antagonist compound design using a combined mutagenesis/modeling approachMarkus Metz, Elyse Bourque, Jean Labrecque, et al.
Virology|March 11, 2011
HIV-1 entry inhibition by small-molecule CCR5 antagonists: a combined molecular modeling and mutant study using a high-throughput assayJean Labrecque, Markus Metz, Gloria Lau, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2012
Discovery of P2X3 selective antagonists for the treatment of chronic painLouis-David Cantin, Malken Bayrakdarian, Christophe Buon, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Biochemical Pharmacology|December 8, 2011
The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitorRenee M Mosi, Virginia Anastassova, Jennifer Cox, et al.
Biochemical Pharmacology|June 23, 2009
Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4Veronique Bodart, Virginia Anastassov, Marilyn C Darkes, et al.
Lab on a Chip|May 27, 2025
A combined digital microfluidic test for assessing infection and immunity status for viral disease in salivaN Sathishkumar, Jose Gilberto Camacho Valenzuela, Nguyen H Le, et al.
Pageof 2